NCT07186387CompletedPhase 2
Study of LW402 in Moderate-to-Severe Atopic Dermatitis
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of LW402 in Patients With Moderate-to-Severe Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 2 Oct 2025
Brief summary (registry, in English)
This is a multi-center, randomized, double blind, placebo-controlled phase 2 study to evaluate the efficacy, safety, PK and PD ofLW402 in patients with moderate-to-severe atopic dermatitis.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 144 (actual)
- First submitted
- 15 Sept 2025
- Start date
- 11 May 2023
- Primary completion date
- 25 Sept 2024
- Lead sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07186387
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 144
- From 11 May 2023 to the primary completion date, 25 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not enough washing-out period for previous therapy. Concurrent disease/status which may potentially affect the efficacy/safety judgement.
- pregnancy. Other.
Who the study is looking for
- Diagnosed with AD for at least 12 months before Screening, with below requirements: 1) EASI score ≥16 at Screening and Baseline; 2) IGA score ≥3 at Screening and Baseline; 3) ≥10% BSA of AD involvement at Screening and Baseline
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.